Technology News and Research

RSS

St. Jude Medical announces first enrollments in LEADLESS Pacemaker Observational Study

St. Jude Medical, Inc., a global medical device company, today announced the first enrollments in the company’s LEADLESS Pacemaker Observational Study evaluating the Nanostim leadless pacing technology. The Nanostim pacemaker received CE Mark in 2013, and post-approval implants have occurred in the UK, Germany, Italy, Czech Republic, France, Spain, and the Netherlands.

19 Mar 2014

Chemical engineers design way to manufacture peptides in mere hours

Small protein fragments, also called peptides, are promising as drugs because they can be designed for very specific functions inside living cells. Insulin and the HIV drug Fuzeon are some of the earliest successful examples, and peptide drugs are expected to become a $25 billion market by 2018.

19 Mar 2014

Nine fellows selected to receive Dennis Weatherstone Predoctoral Fellowship for next two years

Autism Speaks, the world's leading autism science and advocacy organization, today announced the sixth class of The Dennis Weatherstone Predoctoral Fellows funded by the Stavros Niarchos Foundation.

19 Mar 2014

Mass. cutting ties with insurance exchange website vendor after problems

The contractor, CGI Group, is also the lead contractor on the federal marketplace website.

18 Mar 2014

Scientists build tiny "molecular drill bits" that kill bacteria by bursting through their protective cell walls

In response to drug-resistant "superbugs" that send millions of people to hospitals around the world, scientists are building tiny, "molecular drill bits" that kill bacteria by bursting through their protective cell walls.

18 Mar 2014

GenSpera enrolls first patient in Phase II trial of compound G-202 in patients with glioblastoma multiforme

GenSpera, Inc. (OTCQB:GNSZ) announced that the first patient was enrolled in the Phase II clinical trial of its lead compound, G-202, in patients who have glioblastoma multiforme (GBM), the most prevalent type of primary brain cancer.

18 Mar 2014

Study: Just a fifth of people with hearing problems use hearing aid

Just a fifth of people with hearing problems wear a hearing aid, a study by The University of Manchester has found.

From The University of Manchester 18 Mar 2014

Ironwood Pharmaceuticals starts Phase IIa clinical study of IW-3718 for gastroesophageal reflux disease

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that dosing has begun in its Phase IIa clinical study of its investigational compound IW-3718 in patients suffering from gastroesophageal reflux disease (GERD) who have not responded adequately to treatment with a proton pump inhibitor (PPI). Data are expected in the first half of 2015.

18 Mar 2014

ChromaTrap™ Chromatin Immunoprecipitation technology receives positive commentary in published paper

Porvair Sciences reports on positive commentary by researchers in published papers citing how using the fast, sensitive ChromaTrap™ Chromatin Immunoprecipitation (ChIP) technology has benefited their research.

From Chromatrap® - Porvair Sciences Ltd 18 Mar 2014

Merck Millipore announces joint development agreement with Sysmex Corporation

Merck Millipore, the Life Science division of Merck, today announced a clinical research, licensing and joint development agreement with Sysmex Corporation of Japan.

From Sysmex America, Inc. 18 Mar 2014

High-precision Lens Profiler from Phasefocus assists practitioners studying clinical complications arising from corneal oxygen deficiency

Phase Focus Ltd (Phasefocus), the company that is revolutionising microscopy and imaging with the Phasefocus Virtual Lens®, reports on how optical lens practitioners are using the Phasefocus high-precision Lens Profiler to study potential clinical complications arising from corneal oxygen deficiency.

From Phase Focus Limited 18 Mar 2014

Study: Identifying biomarkers could lead to earlier detection of preeclampsia

Identifying biomarkers could lead to earlier detection of preeclampsia, which in turn can lead to healthier mothers and children, according to a collaborative study from the Centre of Molecular Inflammation Research (CEMIR) and the MR Cancer Group at the Norwegian University of Science and Technology (NTNU).

18 Mar 2014

Trovagene reports net loss of $1 million for fourth quarter 2013

Trovagene, Inc., a developer of cell-free molecular diagnostics, today reported its financial results for the quarter and the year ended December 31, 2013.

18 Mar 2014

eZono 4000 tablet ultrasound system with eZGuide technology receives FDA clearance

eZono AG, a private corporation designing, developing and distributing state of the art tablet ultrasound systems, today announced it received 510(k) clearance from the FDA for its eZono 4000 dedicated procedural guidance system with eZGuide technology, providing any plane freehand navigation.

18 Mar 2014

Technology News and Research

St. Jude Medical announces first enrollments in LEADLESS Pacemaker Observational Study

Chemical engineers design way to manufacture peptides in mere hours

Nine fellows selected to receive Dennis Weatherstone Predoctoral Fellowship for next two years

Mass. cutting ties with insurance exchange website vendor after problems

Scientists build tiny "molecular drill bits" that kill bacteria by bursting through their protective cell walls

GenSpera enrolls first patient in Phase II trial of compound G-202 in patients with glioblastoma multiforme

Study: Just a fifth of people with hearing problems use hearing aid

Ironwood Pharmaceuticals starts Phase IIa clinical study of IW-3718 for gastroesophageal reflux disease

ChromaTrap™ Chromatin Immunoprecipitation technology receives positive commentary in published paper

Merck Millipore announces joint development agreement with Sysmex Corporation

High-precision Lens Profiler from Phasefocus assists practitioners studying clinical complications arising from corneal oxygen deficiency

Study: Identifying biomarkers could lead to earlier detection of preeclampsia

Trovagene reports net loss of $1 million for fourth quarter 2013

eZono 4000 tablet ultrasound system with eZGuide technology receives FDA clearance

S. pneumoniae thrives in human saliva

Study shows only 23% of seasonal and pandemic flu caused symptoms

AMN Healthcare makes strategic investment in PipelineRx

Scientists develop new water purifier that could work with sunlight

Self-assembling DNA cages hold potential promise in drug delivery

Researchers present science and engineering research in Parliament

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News